Home » Topics » BioWorld Science

BioWorld Science
RSS

PRISM BioLab discovers Notch signaling inhibitors

May 4, 2022

New MRGPRX2 antagonists identified at GlaxoSmithKline

May 4, 2022

Storm Therapeutics divulges new METTL3 inhibitors

May 4, 2022

GTX-0196 shows complete tumor growth suppression in models of AML

May 4, 2022

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

May 3, 2022

Novel TRPC5 inhibitors show potential for the treatment of CKD

May 3, 2022

Ring Therapeutics describes in vitro system enabling human anellovirus production

May 3, 2022

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

May 3, 2022

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

May 3, 2022

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026